DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
Adoptive T cell therapy using an allogeneic T cell graft is an encouraging therapeutic approach in cancer, but issues such as graft-versus-host disease can hinder applicability. Here, the authors show that DOT1L inhibition or DUSP6 overexpression in T cells attenuates graft-versus-host disease but r...
Saved in:
Main Authors: | Yuki Kagoya, Munehide Nakatsugawa, Kayoko Saso, Tingxi Guo, Mark Anczurowski, Chung-Hsi Wang, Marcus O. Butler, Cheryl H. Arrowsmith, Naoto Hirano |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/d6ce55cb15b249f6b173e89e668c2976 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway
by: Yuki Yamashita, et al.
Published: (2017) -
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
by: Yan-Ruide Li, et al.
Published: (2021) -
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
by: Christopher Sloas, et al.
Published: (2021) -
Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.
by: Peter D Kraus, et al.
Published: (2012) -
Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
by: Uroosa Ibrahim, et al.
Published: (2021)